SCHEMBL25856203

SCHEMBL25856203

C1CN(C2CCN(CC3CNC3)C2)CCN1

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.38
HPGD P15428 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GBA1 P04062 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25815809 0.89 HTR6 (0.40) HTR6HPGDKMT2ASMN1; SMN2
SCHEMBL26507722 0.85 CHRM5 (0.46) HTR6SMN1; SMN2GBA1
SCHEMBL24480854 0.83 HTR6 (0.33) HTR6HPGDKMT2ASMN1; SMN2
SCHEMBL24480695 0.83 ACHE (0.43)
SCHEMBL2547787 0.78 CHRM5 (0.39) HTR6HPGDKMT2ASMN1; SMN2GBA1
SCHEMBL25103854 0.77 KMT2A (0.37) HTR6HPGDKMT2ASMN1; SMN2
SCHEMBL24480693 0.77 GBA1 (0.47) HTR6HPGDKMT2ASMN1; SMN2GBA1
SCHEMBL24033622 0.76 JAK2 (0.35)
SCHEMBL24032937 0.76 JAK2 (0.35)
SCHEMBL25856130 0.76 ACHE (0.46) GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed